The Cooper Companies, Inc. Common Stock (COO)
The Cooper Companies, Inc. (COO) is a global medical device company that specializes in designing, manufacturing, and marketing healthcare products, primarily in the fields of vision correction and women's health. The company's vision segment offers contact lenses and related products, including brands like CooperVision, while its women’s health segment develops and distributes medical devices for the treatment of gynecological conditions. Founded in 1979 and headquartered in Pleasanton, California, Cooper Companies is known for its innovation and focus on patient healthcare solutions.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 11, 2023 | $0.03 | 2023-07-26 | 2023-07-27 |
| February 10, 2023 | $0.03 | 2023-01-20 | 2023-01-23 |
| August 11, 2022 | $0.03 | 2022-07-26 | 2022-07-27 |
| February 9, 2022 | $0.03 | 2022-01-20 | 2022-01-21 |
| August 11, 2021 | $0.03 | 2021-07-26 | 2021-07-27 |
Dividends Summary
- The Cooper Companies, Inc. Common Stock has issued 40 dividend payments over the past 19 years
- The most recent dividend was paid 803 days ago, on August 11, 2023
- The highest dividend payed out to investors during this period was $0.03 per share
- The average dividend paid during this period was $0.03 per share.
Company News
Activist investor Jana Partners has taken a stake in Cooper Companies and is pushing for strategic alternatives, including a potential merger between Cooper's contact lens division and Bausch + Lomb to improve shareholder value.
Cooper Companies reported Q3 fiscal 2025 revenue of $1.06 billion, slightly meeting analyst estimates but falling short of internal expectations. Despite a 6% revenue increase and 15% growth in adjusted net income, the stock dropped 13% due to lower-than-anticipated organic growth.
The U.S. in vitro fertilization market is expected to reach $7.24 billion by 2030, driven by the rising prevalence of infertility, advancements in IVF technology, and a shift in societal attitudes towards family planning. Regulations and increased public awareness also play a crucial role in market dynamics.
The Cooper Companies is well-positioned for growth, driven by strong prospects in its CooperVision and CooperSurgical business segments. However, unfavorable currency movements and rising costs continue to impact revenues and margins.
Jefferies upgraded Cooper Companies' stock to 'Buy' from 'Hold', citing the company's strong positioning in the contact lens market, driven by factors like customer upgrades to daily silicone hydrogel lenses and Cooper's leadership in managing myopia.
